Plasma-mediated gut protection after hemorrhagic shock is lessened in syndecan-1-/- Mice

Shock

Volumn 44, Issue 5, 2015, Pages 452-457

  Ban, Kechen ^a   Peng, Zhanglong ^b   Pati, Shibani ^c,d   Witkov, Richard B ^e   Park, Pyong Woo ^f   Kozar, Rosemary A ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

ADAM 17; syndecan 1 KO mice; TNF alpha

Indexed keywords

DISINTEGRIN; FRESH FROZEN PLASMA; METALLOPROTEINASE; RINGER LACTATE SOLUTION; SYNDECAN 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; ADAM17 PROTEIN, MOUSE; SDC1 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTERITIS; HEMORRHAGIC SHOCK; INTESTINAL TISSUE; INTESTINE INJURY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLASMA; PROTEIN EXPRESSION; SMALL INTESTINE; WILD TYPE; ANIMAL; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETICS; INTESTINAL DISEASES; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SHOCK, HEMORRHAGIC;

ADAM PROTEINS; ADAM17 PROTEIN; ANIMALS; DISEASE MODELS, ANIMAL; ENTERITIS; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE, KNOCKOUT; PLASMA; SHOCK, HEMORRHAGIC; SYNDECAN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945477961     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000452     Document Type: Article

References (32)

1. Kauvar DS, Lefering R, Wade CE: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 60:S3-S11, 2006.
2. Cotton BA, Reddy N, Hatch QM, Lefebrvre E, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Holcomb JB: Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg 254(4):598-605, 2011.
3. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, et al.: PROMMTT Study Group. The prospective, observational, multicenter, massive transfusion study, PROMMTT: comparative effectiveness of a time-varying treatment and competing risks. JAMA Surg 148(2):127-136, 2013.
4. Holcomb JB, Tilley BC, Baraniuk S, Fox EF, Wade CE, Podbielski J, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, et al.: PROPPR Study Group: transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma. The PROPPR randomized clinical trial. JAMA 313(5):471-482, 2015.
5. Jenkins DH, Rappold JF, Badloe JF, Berséus O, Blackbourne L, Brohi KH, Butler FK, Cap AP, Cohen MJ, Davenport R, et al.: THOR position paper on remote damage control resuscitation: definitions, current practice and knowledge gaps. Shock 41(Suppl 1):3-12, 2014.
6. Peng Z, Pati S, Potter D, Brown R, Holcomb JB, Grill R, Wataha K, Park PW, Xue H, Kozar RA: Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan-1. Shock 40(3):195-202, 2013.
7. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A: Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112:1289-1295, 2011.
8. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR: A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, Protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 254(2):194-200, 2011.
9. Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 83(2):388-396, 2009.
10. Grundmann S, Fink K, Rabadzhieva L, Bourgeois N, Schwab T, Moser M, Bode C, Busch HJ: Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 83(6):715-720, 2012.
11. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Bruno R, et al.: Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116:1896-1906, 2007.
12. Bode L, Salvestrini C, Park PW, Li JP, Esko JD, Yamaguchi Y, Murch S, Freeze HH: Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 118(1):229-238, 2008.
13. Peng Z, Ban K, Sen A, Grill R, Park PY, Costantini TW, Lin W, Kozar RA: Syndecan-1 plays a novel role in enteral glutamine's gut protective effects of the post ischemic gut. Shock 38(1):57-62, 2012.
14. Reino DC, Palange D, Feketeova E, Bonitz RP, Xu da Z, Lu Q, Sheth SU, Pen-a G, Ulloa L, De Maio A, et al.: Activation of toll-like receptor 4 is necessary for trauma hemorrhagic shock-induced gut injury and polymorphonuclear neutro-phil priming. Shock 38(1):107-114, 2012.
15. Jung C, Fuernau G, Muench P, Desch S, Eitel I, Schuler G, Adams V, Figulla HR, Thiele H: Impairment of the endothelial glycocalyx in cardiogenic shock and its prognostic relevance. Shock 43:450-451, 2015.
16. Wang X, Chen Y, Song Y, Zhang S, Xie X, Wang X: Activated syndecan-1 shedding contributes to mice colitis induced by dextran sulfate sodium. Dig Dis Sci 56:1047-1056, 2011.
17. Yablecovitch D, Stein A, Shabat-Simon M, Naftali T, Gabay G, Laish I, Oren A, Konikoff FM: Soluble syndecan-1 levels are elevated in patients with inflammatory bowel disease. Dig Dis Sci 60:2419-2426, 2015.
18. Zhang S, Qing Q, Wang Q, Xu J, Zhi F, Park PW, Zhang Y, Chen Y: Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease. Inflamm Bowel Dis 19(5):1025-1033, 2013.
19. Fishman JE, Sheth SU, Levy G, Alli V, Lu Q, Xu D, Qin Y, Qin X, Deitch EA: Intraluminal nonbacterial intestinal components control gut and lung injury after trauma hemorrhagic shock. Ann Surg 260(6):1112-1120, 2014.
20. Hayashida K, Parks WC, Park PW: Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 114(14):3033-3043, 2009.
21. Haywood-Watson RJ, Holcomb JB, Gonzalez EA, Peng Z, Pati S, Park PW, Wang WW, Zaske AM, Menge T, Kozar RA: Modulation of Syndecan-1 shedding after hemorrhagic shock and resuscitation. PLoS One 6(8):e23530, 2011.
22. Straat M, Müller MC, Meijers JC, Arbous MS, Spoelstra-de Man AM, Beursk-ens CJ, Vroom MB, Juffermans NP: Effect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non-bleeding critically ill patients: a prospective substudy of a randomized trial. Crit Care 19:163, 2015.
23. Gooz M: ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol 45(2):146-169, 2010.
24. Pruessmeyer J, Martin C, Hess FM, Schwartz N, Schmidt S, Kogel T, Hoettecke N, Schmidt B, Sechi A, Uhlig S, et al.: A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and-4 by lung epithelial cells. J Biol Chem 285(1):555-564, 2010.
25. Cesaro A, Abakar MA, Brest P, Lassalle S, Selva E, Filippi J, Hebuterne X, Hugot JP, Doglio A, Galland F, et al.: Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 296(6):G1332-G1343, 2009.
26. Dusterhoft S, Hobel K, Oldefest M, Lokau J, Waetzig GH, Chalaris A, Garbers C, Scheller J, Rose-John S, Lorenzen I, et al.: A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin six receptor. J Biol Chem 289(23):16336-16348, 2014.
27. Jastrow K, Gonzalez EA, McGuire MF, Suliburk JW, Kozar RA, Iyengar S, Motschall DA, McKinley BA, Moore FA, Mercer DW: Early cytokine production risk stratifies trauma patients for multiple organ failure. J Am Coll Surg 209:320-331, 2009.
28. Namas R, Ghuma A, Torres A, Polanco P, Gomez H, Barclay D, Gordon L, Zenker S, Kim HK, Hermus L, et al.: An adequately robust early TNF-alpha response is a hallmark of survival following trauma/hemorrhage. PLoS One 4(12):e8406, 2009.
29. Yang Y, MacLeod V, Miao HQ, Theus A, Zhan F, Shaughnessy Jr JD, Sawyer J, Li JP, Zcharia E, Vlodavsky I, et al.: Heparanase enhances sydnecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem 282:13326-13333, 2007.
30. Purushothaman A, Chen L, Yang Y, Sanderson RD: Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem 283(47):32628-32636, 2008.
31. Henry-Stanley MJ, Zhang B, Erlandsen SL, Wells CL: Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on enterocyte shedding of syndecan-1 and associated decreases in internalization of Listeria monocyto-genes and Staphylococcus aureus. Cytokine 34(5-6):252-259, 2006.
32. Kainulainen V, Nelimarkka L, Jarvelainen H, Laato M, Jalkanen M, Elenius K: Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-alpha. J Biol Chem 271(31):18759-18766, 1996.